Association between serum ferritin and microalbuminuria in Type 2 diabetes in Taiwan

Diabetic Medicine

Volumn 30, Issue 11, 2013, Pages 1367-1373

  Hsu, Y H ^a,b,c   Huang, M C ^d   Chang, H Y ^e   Shin, S J ^f   Wahlqvist, M L ^e   Chang, Y L ^e   Hsu, K C ^e   Hsu, C C ^b,e  

^a CHIA YI CHRISTIAN HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c MIN HWEI COLLEGE OF HEALTH CARE MANAGEMENT   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; GLUCOSE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPERFERRITINEMIA; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; TAIWAN;

ALBUMINURIA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FERRITINS; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TAIWAN;

EID: 84885941476     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12257     Document Type: Article

References (25)

1. Andrews NC. Disorders of iron metabolism. N Engl J Med 1999; 341: 1986-1995.
2. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. J Am Med Assoc 2004; 291: 711-717.
3. Sun L, Franco OH, Hu FB, Cai L, Yu Z, Ji H et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2008; 93: 4690-4696.
4. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
5. Canturk Z, Cetinarslan B, Tarkun I, Canturk NZ. Serum ferritin levels in poorly and well-controlled diabetes mellitus. Endocr Res 2003; 29: 299-306.
6. Kim MK, Baek KH, Song KH, Kang MI, Choi JH, Bae JC et al. Increased serum ferritin predicts the development of hypertension among middle-aged men. Am J Hypertens 2012; 25: 492-497.
7. Piperno A, Trombini P, Gelosa M, Mauri V, Pecci V, Vergani A et al. Increased serum ferritin is common in men with essential hypertension. J Hypertens 2002; 20: 1513-1518.
8. Ramakrishnan U, Kuklina E, Stein AD. Iron stores and cardiovascular disease risk factors in women of reproductive age in the United States. Am J Clin Nutr 2002; 76: 1256-1260.
9. Jehn M, Clark JM, Guallar E. Serum ferritin and risk of the metabolic syndrome in US adults. Diabetes Care 2004; 27: 2422-2428.
10. Cheng HL, Bryant C, Cook R, O'Connor H, Rooney K, Steinbeck K. The relationship between obesity and hypoferraemia in adults: a systematic review. Obes Rev 2012; 13: 150-161.
11. Kim CH, Kim HK, Bae SJ, Park JY, Lee KU. Association of elevated serum ferritin concentration with insulin resistance and impaired glucose metabolism in Korean men and women. Metabolism 2011; 60: 414-420.
12. Wrede CE, Buettner R, Bollheimer LC, Scholmerich J, Palitzsch KD, Hellerbrand C. Association between serum ferritin and the insulin resistance syndrome in a representative population. Eur J Endocrinol 2006; 154: 333-340.
13. Hermans MP, Ahn SA, Amoussou-Guenou KD, Balde NM, Rousseau MF. Do high ferritin levels confer lower cardiovascular risk in men with Type 2 diabetes? Diabet Med 2010; 27: 417-422.
14. Huang MC, Hsu CC, Wang HS, Shin SJ. Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care 2010; 33: 233-239.
15. 1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Diabetologia 2012; 55: 3163-3172.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
17. Mojiminiyi OA, Marouf R, Abdella NA. Body iron stores in relation to the metabolic syndrome, glycemic control and complications in female patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2008; 18: 559-566.
18. Barzilay JI, Peterson D, Cushman M, Heckbert SR, Cao JJ, Blaum C et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the Cardiovascular Health Study. Am J Kidney Dis 2004; 44: 25-34.
19. Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T et al. Association between serum C-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Intern Med 2004; 43: 919-925.
20. Tsioufis C, Dimitriadis K, Andrikou E, Thomopoulos C, Tsiachris D, Stefanadi E et al. ADMA, C-reactive protein, and albuminuria in untreated essential hypertension: a cross-sectional study. Am J Kidney Dis 2010; 55: 1050-1059.
21. Fleming RE, Ponka P. Iron overload in human disease. N Engl J Med 2012; 366: 348-359.
22. Minamiyama Y, Takemura S, Kodai S, Shinkawa H, Tsukioka T, Ichikawa H et al. Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. Am J Physiol Endocrinol Metab 2010; 298: E1140-1149.
23. Tajima S, Ikeda Y, Sawada K, Yamano N, Horinouchi Y, Kihira Y et al. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab 2012; 302: E77-86.
24. Ghio AJ, Hilborn ED, Stonehuerner JG, Dailey LA, Carter JD, Richards JH et al. Particulate matter in cigarette smoke alters iron homeostasis to produce a biological effect. Am J Respir Crit Care Med 2008; 178: 1130-1138.
25. National Kidney Foundation. KDOQI Clinical Practice Guidelines. Available at http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p5_lab_g5.htm Last accessed 7 June 2012.